Micro Labs Limited Apixaban Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Apixaban Export Records India — #7 Exporter, 68 Shipments, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Apixaban

India Pharmaceutical Trade Intelligence

$179.9M171 Suppliers98 CountriesHS 30049099

ExportsIndia → LEBANON41.8%India → CANADA18.3%

ImportsGERMANY → India$14.0B BELGIUM → India$17.4M

Micro Labs Limited — Apixaban Exporter #7 | $3.4M Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Apixaban Exporter Profile

Indian Pharmaceutical Exporter · #7 for Apixaban · $3.4M export value · DGFT Verified

Micro Labs Limited is the #7 Indian exporter of Apixaban with $3.4M in export value and 68 verified shipments. Micro Labs Limited holds a 1.9% market share in Apixaban exports across 14 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Apixaban Export Profile: Buyers & Destinations

Micro Labs Limited Apixaban export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Apixaban?

Country	Value	Shipments	Share
MALTA	$800.0K	16	36.5%
IRAQ	$621.9K	14	28.4%
MOROCCO	$340.0K	12	15.5%
UNITED KINGDOM	$132.7K	5	6.0%
JORDAN	$100.0K

Who Are the Top Buyers of Apixaban from Micro Labs Limited?

Buyer	Country	Value	Orders
PHARMADOX HEALTHCARE LTD	MALTA	$700.0K	14
HAWKARY PHARMACEUTICAL COMPANY	IRAQ	$292.4K	6
HAWKARY PHARMACEUTICAL COMPANY#	IRAQ	$229.5K	6
PHARMIS SARL	MOROCCO	$200.0K	6
PHARMIS	MOROCCO	$140.0K	6
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$132.7K	5
AL KAWKAB SCIENTIFIC BUREAU	JORDAN	$100.0K	2
AL-KAWKAB SCIENTIFIC BUREAU	IRAQ	$100.0K	2
BROWN AND BURK PHILIPPINES INC	PHILIPPINES	$87.4K	2
PHARMADOX HEALTHCARE LTD,	MALTA	$50.0K	1

Micro Labs Limited supplies Apixaban to 21 buyers globally. The largest buyer is PHARMADOX HEALTHCARE LTD (MALTA), followed by HAWKARY PHARMACEUTICAL COMPANY (IRAQ) and HAWKARY PHARMACEUTICAL COMPANY# (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Apixaban Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
APIXABAN BIOGARAN 2,5 MG ( (APIXABAN TAB	$150.0K	3
APIXABAN BIOGARAN 5 MG ( (APIXABAN TABLE	$150.0K	3
APIXABAN BIOGARAN 5 MG(APIXABAN TABLETS	$150.0K	3
APIVAS 2.5 (APIXABAN TABLETS 2.5MG) ( 6X	$100.0K	2
APIVAS 5 (APIXABAN TABLETS 5MG) ( 6X10'S	$100.0K	2
APIVAS 5 ( (Apixaban Tablets 5mg) ) ( 6X10'S ) ( QTY- 4867.000 )	$75.0K	2
APIVAS 2.5 ( (Apixaban Tablets 2.5mg) )( 6X10'S ) ( QTY- 4896.000 )	$61.7K	2
APIVAS 5 APIXABAN TABLETS 5MG 6X10 S QTY 4800 TAX INV NO 712202404 14 03 2023	$50.0K	1
APIXABAN BIOGARAN 5 MG APIXABAN TABLETS 5 MG PO 4600042869 DT 01 12 2022PACK 3X20S TAX INV 706204473	$50.0K	1
APIXABAN BIOGARAN 5 MG (APIXABAN TABLET	$50.0K	1

Micro Labs Limited exports 57 distinct Apixaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APIXABAN BIOGARAN 2,5 MG ( (APIXABAN TAB with 3 shipments worth $150.0K.

How Does Micro Labs Limited Compare to Nearest Apixaban Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	UNISON PHARMACEUTICALS PRIVATE LIMITED	$3.9M	114	5	$34.2K
6	NATCO PHARMA LIMITED	$3.6M	72	7	$50.0K
7	MICRO LABS LIMITED ★	$3.4M	68	14	$50.0K
9	EMCURE PHARMACEUTICALS LIMITED	$3.0M	122	2	$24.4K
12	SAVA HEALTHCARE LIMITED	$1.4M	290	1	$5.0K

Micro Labs Limited ranks #7 among 171 Indian Apixaban exporters. Average shipment value of $50.0K compared to the market average of $497.1K. The closest competitors by value are UNISON PHARMACEUTICALS PRIVATE LIMITED and NATCO PHARMA LIMITED.

Which Indian Ports Ship Apixaban Exports?

Port	Shipments	% Share
SAHAR AIR	724	16.1%
SAHAR AIR CARGO ACC (INBOM4)	674	15.0%
DELHI AIR CARGO ACC (INDEL4)	607	13.5%
DELHI AIR	364	8.1%
MUNDRA SEA	146	3.3%
Bombay Air	134	3.0%
JNPT/ NHAVA SHEVA SEA	131	2.9%
AHEMDABAD AIR ACC (INAMD4)	129	2.9%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Apixaban Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 68 individual customs records matching Micro Labs Limited exporting Apixaban, covering 57 formulations to 14 countries via 21 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 98+ countries, 371+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Apixaban

Apixaban

Micro Labs Limited — Apixaban Exporter Profile

Micro Labs Limited — Apixaban Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Apixaban?

Who Are the Top Buyers of Apixaban from Micro Labs Limited?

What Is India's Total Apixaban Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Apixaban Exports?

How Does Micro Labs Limited Compare to Other Indian Apixaban Exporters?

What Apixaban Formulations Does Micro Labs Limited Export?

How Does Micro Labs Limited Compare to Nearest Apixaban Exporters?

Which Indian Ports Ship Apixaban Exports?

Geopolitical & Trade Policy Impact on Micro Labs Limited's Apixaban Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Apixaban Export Data from Micro Labs Limited

Apixaban Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source